Cases 1 - 10 of 262
Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc.
as 23-2254
Plaintiff / Appellee:
MERCK SHARP & DOHME B.V. and MERCK SHARP & DOHME, LLC
Defendant / Appellant:
AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA LTD., USV PRIVATE LIMITED and others
Defendant:
LUPIN LTD., LUPIN PHARMACEUTICALS, INC. and LUPIN INC.
Bayer Pharma AG, et al v. Mylan Pharmaceuticals Inc. et al
as 1:2022cv01228
Plaintiff:
Bayer Pharma AG and Bayer AG
Counter Defendant:
Janssen Pharmaceuticals Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Counter Claimant:
Mylan Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG, et al v. Mylan Pharmaceuticals Inc. et al
as 1:2022cv00063
Plaintiff:
Bayer Pharma AG,, Bayer AG, and Janssen Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MOMENTA PHARMACEUTICALS, INC. v. MYLAN PHARMACEUTICALS, INC. et al
as 2:2022cv00750
Plaintiff:
MOMENTA PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS, INC., MYLAN, INC., VIATRIS, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAUSCH HEALTH IRELAND LIMITED et al v. MYLAN LABORATORIES LTD. et al
as 1:2022cv00020
Plaintiff:
Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc
Defendant:
Mylan Laboratories Ltd., Agila Specialties Inc., Mylan API US LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al
as 1:2021cv00146
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc., Mylan Laboratories Limited and others
Cause Of Action: 35 U.S.C. § 271
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Mylan Pharmaceuticals Inc. et al
as 1:2021cv01742
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals Inc.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Pharma AG et al v. Mylan Pharmaceuticals Inc. et al
as 1:2021cv00099
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
BAUSCH HEALTH IRELAND LIMITED et al v. MYLAN LABORATORIES LTD et al
as 2:2021cv00573
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED and SALIX PHARMACEUTICALS, INC
Defendant:
AGILA SPECIALTIES INC, MYLAN INC, VIATRIS INC and others
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
